How to discontinue Paroxetine (Selective Serotonin Reuptake Inhibitor) 10 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Safely Discontinue Paroxetine 10 mg

Paroxetine should be discontinued through a gradual tapering schedule over several weeks rather than abrupt cessation to minimize withdrawal symptoms.

Understanding Paroxetine Discontinuation

Paroxetine is a selective serotonin reuptake inhibitor (SSRI) with a relatively short half-life that is associated with a significant risk of discontinuation syndrome when stopped abruptly. The FDA label specifically recommends a taper-phase regimen rather than abrupt discontinuation 1.

Withdrawal Symptoms to Monitor

Discontinuation symptoms typically appear within 24-48 hours after reducing or stopping paroxetine and may include:

  • Physical symptoms: dizziness, vertigo, electric shock-like sensations, nausea, fatigue, flu-like symptoms, headache, paresthesia
  • Psychological symptoms: anxiety, irritability, agitation, confusion, insomnia, abnormal dreams

These symptoms are generally mild to moderate but can be distressing and impact daily functioning 2, 3.

Recommended Tapering Schedule

For paroxetine 10 mg, follow this tapering schedule:

  1. Weeks 1-2: Reduce from 10 mg to 5 mg daily
  2. Weeks 3-4: Take 5 mg every other day
  3. Weeks 5-6: Discontinue completely

Key Points for Successful Tapering:

  • Slower is better: If withdrawal symptoms emerge, slow the taper further by extending each step to 2-4 weeks 2
  • Use liquid formulation: For more precise dose reductions, consider using the liquid formulation of paroxetine if available
  • Monitor closely: Assess for withdrawal symptoms during each step of the taper
  • Be prepared to adjust: If intolerable symptoms occur, return to the previous dose and resume tapering at a more gradual rate 1

Special Considerations

High-Risk Patients

Patients with the following factors may need an even more gradual taper:

  • Prior history of discontinuation symptoms
  • Longer duration of paroxetine treatment
  • Higher doses prior to tapering
  • Concomitant medications
  • Alcohol consumption 3

Managing Breakthrough Symptoms

If significant withdrawal symptoms occur during tapering:

  1. Return to the previous well-tolerated dose
  2. Stabilize for 1-2 weeks
  3. Resume tapering with smaller decrements (e.g., 2.5 mg reductions using the liquid formulation)
  4. Extend the time between dose reductions 1, 2

Common Pitfalls to Avoid

  1. Mistaking withdrawal for relapse: Withdrawal symptoms typically appear within days of dose reduction and include distinctive symptoms like dizziness and electric shock sensations, whereas depression relapse usually develops more gradually 2

  2. Tapering too quickly: Paroxetine has been associated with more severe discontinuation symptoms compared to other SSRIs due to its shorter half-life 3, 4

  3. Poor patient education: Ensure patients understand the difference between withdrawal symptoms and relapse to prevent unnecessary concern 2

  4. Inadequate monitoring: Regular follow-up during the tapering process is essential to adjust the schedule as needed 5

By following this structured approach to discontinuing paroxetine, the risk of significant withdrawal symptoms can be minimized while ensuring patient comfort and safety throughout the process.

References

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Research

[Paroxetine withdrawal syndrome].

Annales de medecine interne, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.